Research studies have shown that in some cases, cannabis can act as a bronchodilator because of the cannabinoids it contains. Cannabinoids are the key component in medical cannabis, and its two most prominent (THC and CBD) have shown promise in alleviating COPD symptoms when administered under clinical supervision and careful monitoring.
Through investigation and experimentation, researchers have been able to demonstrate how CBD and THC have the ability to reduce airway inflammation and increase forced vital capacity (FVC) which improves overall lung function. This can make cannabinoids a powerful tool for patients with COPD who are struggling with conventional medicines.
Please note: smoking puts people at a much higher risk of developing COPD, and it also greatly exacerbates symptoms. Medical cannabis treatments are never prescribed to be smoked, and smoking cannabis is illegal in the UK.
COPD Medical cannabis treatments are typically prescribed as cannabis oils, to be absorbed under the tongue, or occasionally as dried flower, to be vaporised in a safe device, and then inhaled into the lungs.
